Oxford Immunotec Global PLC announced that experienced diagnostics executives Ronald Andrews Jr. and A. Scott Walton will join the company's Board of Directors effective November 4, 2015. The addition of Mr. Andrews and Mr. Walton to Oxford Immunotec's Board of Directors increases the total number of directors to eight.
Mr. Andrews most recently served as President of the Genetic Sciences Division of Thermo Fisher Scientific, a position he assumed upon Thermo Fisher's acquisition of Life Technologies Corporation, where he had been the President of the Medical Sciences Venture. Following the acquisition, Mr. Andrews led the integration of Life Technologies' next generation sequencing technology into the Thermo Fisher product line. Mr. Walton is currently the Chief Executive Officer of Ameritox.